SCHEMBL4084593

SCHEMBL4084593

CC1(C2CC2)C(C2C3CC4CC(C3)CC2C4)NC(=O)N1C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4084383 0.84 HSD11B1 (0.34)
SCHEMBL4088772 0.84
SCHEMBL4083372 0.69 HSD11B1 (0.34)
SCHEMBL4088781 0.68 HSD11B1 (0.36)
SCHEMBL76826 0.63 EPHX2 (0.34)
SCHEMBL4089100 0.62
SCHEMBL4082735 0.60 EPHX2 (0.33)
SCHEMBL74761 0.60 EPHX2 (0.39)
SCHEMBL75019 0.57 EPHX2 (0.33)
SCHEMBL4084394 0.55 EPHX2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2104665-A2 IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS FOR DIABETES F. Hoffmann-Roche AG (CH) 2009-09-30 EP disclosed
WO-2008046758-A2 IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS FOR DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-24 WO disclosed